Cita APA (7a ed.)

Tsubata, Y., Tanino, R., & Isobe, T. (2021). Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance. MDPI AG.

Cita Chicago Style (17a ed.)

Tsubata, Yukari, Ryosuke Tanino, y Takeshi Isobe. Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance. MDPI AG, 2021.

Cita MLA (8a ed.)

Tsubata, Yukari, et al. Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance. MDPI AG, 2021.